Journal of neurosurgery · 1987 · 112 citations · 32 references
MedicineOncologyPharmacologyCancer PharmacologyHormone BiochemistrySteroid BiochemistryGonadal Steroid HormonesHormonal Cancer TherapyHormonal TherapySteroid Hormone SignalingSteroid PharmacologyControl Group DesignHormone Receptor Binding ProteinsMatched Control GroupSteroid Binding ProteinsSteroid Hormone Binding ProteinsSteroid Hormone PharmacologyTumor Growth DynamicsTumor Volume Measurement
Meningiomas have been shown to have steroid-binding proteins. In vitro, estradiol, progesterone, and the antiestrogen tamoxifen stimulate tumor growth. However, incubation of tumor cells with an antiprogesterone agent results in tumor inhibition. In this investigation, a human meningioma was implanted subcutaneously in athymic nude mice. Two treatment groups were established, one receiving the antiprogesterone agent RU-38486 (10 mg/kg/day in suspension) and the other receiving only vehicle. After 3 months, the tumor growth index (defined as the tumor volume at 3 months divided by the initial tumor volume) was 0.25 +/- 0.46 (mean +/- standard deviation) in the group receiving antiprogesterone and was 1.54 +/- 0.58 in the control group (p = 0.041). Further investigation of the effect of antiprogestational agents on the growth and hormone-binding proteins of other meningiomas will better define the mechanism of their effects.
32
Pathology of Tumours of the Nervous System
Journal of Neuropathology & Experimental Neurology · 1990 · 3.5K citations
British Journal of Ophthalmology · 1970 · 1.1K citations · Full text